Product Wiki · Recalls · EU Safety Gate (RAPEX)

Huivi — recall 0635/09

EU Safety Gate (RAPEX) · Finland · 2009-05-15 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
0635/09
Date of alert
2009-05-15
Country / jurisdiction
Finland
Risk level
Serious risk
Risk type
Chemical
Brand
Accessories
Product category
Clothing, textiles and fashion items
Product type
Scarf
Reported risk: Tuote aiheuttaa kemiallisen riskin kiellettyjen atsoväriaineiden vuoksi; sininen väri vapauttaa 45 mg/kg 3,3'-dimetoksibentsidiiniä, joka ylittää raja-arvon 30 mg/kg. Tuote ei ole kemikaalirajoitusdirektiivin 76/769/ETY mukainen.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Other
Category of measure
Import rejected by the customs authorities
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Scarf

Risk Description (original English): The product poses a chemical risk because of banned azocolourants; the blue colour releases 45 mg/kg of 3,3’-dimethoxybenzidine which exceeds the limit 30 mg/kg. The product does not comply with the Chemical Restrictions Directive 76/769/EEC.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/-15231

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.